JOURNAL OF CELL SCIENCE, with ISSN 0021-9533 and E-ISSN 1477-9137, is a distinguished publication in the field of Cell Biology, released by COMPANY BIOLOGISTS LTD in the United Kingdom. Since its inception in 1966, this journal has served as a vital platform for disseminating cutting-edge research and reviews that significantly advance our understanding of cellular processes and innovations. Currently positioned in the Q1 category within the 2023 rankings, this journal is recognized for its high impact and quality, holding a notable Scopus rank of 120 out of 285 in the Cell Biology category, placing it within the 58th percentile. While not an open-access journal, it provides extensive access options for readers and institutions, ensuring that pivotal research is accessible to a wide audience. With converged publication years leading toward 2024, JOURNAL OF CELL SCIENCE continues to be an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of the intricate workings of cell biology.

Biochemistry Moscow Supplement Series A-Membrane and Cell Biology, published by PLEIADES PUBLISHING INC in the United States, is a pivotal journal in the fields of biochemistry, biophysics, and cell biology. Established in 2008, this journal has become a significant platform for disseminating novel research findings and reviews, fostering advanced studies in membrane dynamics and cellular processes. Although currently ranked in the Q4 quartile across its categories, the journal provides researchers and professionals with open access to a wealth of knowledge, helping to bridge gaps in understanding complex biochemical mechanisms. The journal’s commitment to quality and relevance is evident as it continues to contribute to the academic community through its coverage of innovative and emerging topics in cell and membrane biology. Researchers, practitioners, and students alike will find this resource invaluable for keeping abreast of the latest developments in the ever-evolving landscape of biochemistry and cellular research.

The Annual Review of Biophysics, published by ANNUAL REVIEWS, stands as a premier journal in the field of biophysics, offering an unparalleled collection of comprehensive and insightful reviews that synthesize the latest advancements in biochemistry, bioengineering, cell biology, structural biology, and more. With an impressive Q1 ranking across multiple categories as of 2023, this journal is recognized for its significant contribution to the scientific community, highlighted by its robust Scopus ranking—placing it in the 99th percentile for biophysics and the 96th percentile for structural biology. Operating under an open access policy, the journal ensures a broad dissemination of crucial findings and theoretical advancements. As the field of biophysics continues to expand, the Annual Review of Biophysics remains essential for researchers, professionals, and students seeking to stay informed about pivotal developments that shape our understanding of biological systems at the molecular level. One may refer to the journal for current trends, innovative methodologies, and a wealth of knowledge that drives the field forward.

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES is a prestigious journal dedicated to advancing the field of biomembrane research, published by Elsevier. With a notable track record since its inception in 1967, this journal operates under the dual ISSN 0005-2736 and E-ISSN 1879-2642, and has firmly established itself within the scientific community by ranking in the top tiers of various disciplines, including Q2 in Biochemistry and Cell Biology, and Q1 in Biophysics as of 2023. Its impressive Scopus rankings further underscore its importance, with a rank of 24 in Biophysics reflecting its strong impact on ongoing research. Although it does not offer open access, the journal provides comprehensive insights and breakthroughs essential for scientists, researchers, and advanced students focused on biophysical and biochemical aspects of membranes. By disseminating pivotal findings, BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES contributes significantly to understanding cellular mechanisms, thereby serving as a vital resource for professionals aiming to explore the complexities of biological membranes.

BIOPHYSICAL JOURNAL, published by CELL PRESS, is a leading interdisciplinary platform dedicated to advancing the field of biophysics. With an ISSN of 0006-3495 and an E-ISSN of 1542-0086, this esteemed journal has garnered a prestigious position within the academic community, reflected in its ranking as Q1 in Biophysics for the year 2023. Its Scopus rank of #44/152 in the category of Biochemistry, Genetics, and Molecular Biology showcases its significant influence, with a notable percentile of 71st. Since its inception in 1960, the journal has published cutting-edge research that explores the quantitative and qualitative aspects of biological phenomena, making it essential for researchers, professionals, and students in the field. While the journal operates under a subscription model, its rigorous peer-review process ensures the highest quality of published work, contributing to groundbreaking discoveries and innovations that shape the future of biophysics. For more information or to explore the latest research, please visit the journal’s platform.

SEPARATION SCIENCE AND TECHNOLOGY is a distinguished journal published by Taylor & Francis Inc, offering critical insights and advancements in the fields of chemistry and chemical engineering. With an ISSN of 0149-6395 and E-ISSN of 1520-5754, the journal spans a rich history from 1978 to 2024, providing a platform for scholarly articles that delve into innovative separation processes and technologies. Notably recognized in the 2023 category quartiles, the journal ranks Q2 in Chemical Engineering and Chemistry, alongside Q3 in Filtration and Separation and Process Chemistry and Technology, reflecting its significant impact and relevance in these research areas. With an impressive Scopus ranking, including a rank of #10/19 in Filtration and Separation, SEPARATION SCIENCE AND TECHNOLOGY is crucial for researchers and professionals seeking to enhance their understanding of separation techniques and applications. Although it operates under a subscription model, its contributions remain indispensable for the advancement of knowledge and technologies in separation science.

Bioelectricity, published by MARY ANN LIEBERT, INC, is an esteemed journal dedicated to the interdisciplinary field that bridges biomedical engineering and electrical engineering, promoting research and innovation in the use of electrical signals for biological applications. Since its inception in 2019, the journal has established a solid reputation within the academic community, evidenced by its categorization in the Q3 quartile for Biomedical Engineering, Electrical and Electronic Engineering, and Medicine, alongside a notable Q2 ranking in Transplantation for 2023. With an ISSN of 2576-3105, Bioelectricity serves as a pivotal platform for disseminating cutting-edge research and fostering advancements in technology and medicine, drawing contributions from scholars globally. Although the journal operates under a traditional access model, it remains a critical resource for researchers, professionals, and students keen on exploring the potential of bioelectric phenomena in medical treatments and devices. As the field continues to evolve, Bioelectricity plays a vital role in shaping discussions and insights that propel innovations in health and engineering.

European Biophysics Journal with Biophysics Letters is a leading academic journal published by Springer that focuses on innovative research in the field of biophysics. Founded in 1984, it has consistently provided a platform for the dissemination of high-quality scientific findings, bridging the gap between biophysics and its applications in medicine and related fields. With an ISSN of 0175-7571 and an E-ISSN of 1432-1017, this journal has established itself as a Q2-rated publication in both Biophysics and Miscellaneous Medicine, highlighting its influential role in advancing knowledge and fostering collaboration among researchers. The journal features original research articles, reviews, and technical notes that contribute significantly to our understanding of biological systems at a molecular level. Although it does not offer an open-access model, the journal remains committed to promoting scholarly communication and enhancing the visibility of biophysical research globally. By maintaining a Scopus Rank of #74/152 within the category of Biochemistry, Genetics and Molecular Biology, it positions itself as an essential resource for professionals, researchers, and students aiming to stay at the forefront of biophysical science.

LIPIDS is a renowned peer-reviewed journal published by Wiley, dedicated to the field of lipid research, encompassing biochemistry, molecular biology, and organic chemistry. With its roots dating back to 1966 and a commitment to advancing knowledge until 2024, this journal serves as a vital platform for sharing significant findings in lipid biochemistry and its applications in health and disease. Although it currently does not offer Open Access options, it maintains a respectable standing with a Q3 ranking in Biochemistry and Organic Chemistry, and a Q4 ranking in Cell Biology based on the 2023 category quartiles. Additionally, its Scopus rankings reflect a solid position within the organic chemistry and biochemistry subfields. Published from Germany, LIPIDS caters to researchers, professionals, and students eager to explore the roles of lipids in biological processes and innovatory applications in various scientific disciplines.